CSF2 and myeloid sarcoma: Using microfluidics-based single-cell RNA sequencing (scRNA-seq), we obtained in total 42,969 blood single-cell transcriptomes (five control vs. five MS donors) and 22,357 corresponding CSF single-cell transcriptomes (four control vs. four MS donors).